[关于在临床实践中合理使用surufatinib的中国多学科专家共识 (2024年版) ]
Zhonghua zhong liu za zhi [Chinese journal of oncology]
|October 16, 2024
概括
神经内分泌瘤 (NETs) 在全球范围内正在增加. 苏鲁法提尼布为无法切除的NET提供了一种新的口服治疗选择,专家的共识指导其合理的临床使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经内分泌新生瘤 (NENs) 是多样化的瘤,其全球发病率正在上升.
- 肺部和胃肠道胰腺NEN最常见,影响身体的各种部位.
- 目前的治疗方法包括索马托斯塔丁类似物,抗血管生成药物,核化物疗法和化疗.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


